Drawing for ADRIEN GAGNON

USPTO serial 88025012

ADRIEN GAGNON

Reviewed by CopyMark Law Group

Reg. 6725105Status 700Registered
Filing date
Status date
Registration date
May 24, 2022
Examiner
PARK, JENNY K
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with ADRIEN GAGNON?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Joseph V. Myers III

Joseph V. Myers III SEYFARTH SHAW LLP1075 PEACHTREE STREET, SUITE 2500ATLANTA, GA 30309UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Goods: plant extracts in the form of capsules for improving the health, for reducing the frequency of climateric episodes (hot flashes), improving the neurovegetative state associated with menopause, improving blood cholesterol levels, alleviating excessive perspiration and enabling regulation of a disrupted sleep cycle; Natural products for human use, namely, a vitamin and mineral supplement formula to remedy vitamin and mineral deficiencies; plant extract formulas with calming antioxidant properties, plant extract formulas possessing immune system benefits, to help balance mood swings, aiming at palliating the reduction of estrogen in menopausal women, antioxidants in the form of tablets, for maintaining good health; Natural products for human use, namely, a supplement formula made of vitamins, plants and adaptogenic roots in the form of energizing ampoules, to decrease hyperglycemia and stimulate weakened immune systems and cognitive functions; plant, root, and bark extracts in capsule form for treating lumbar pain, arthritis pain, rheumatic disorders; Natural products for human use, namely, leaf, flower, and bark extracts in the form of capsules for combatting sleep disorders and reducing nervousness; plant extracts in the form of capsules to assist in fighting hypertension or hypercholesterolemia; Natural products for human use, namely, a vitamin and mineral supplement formula in the form of capsules, tablets and ampoules for soothing the symptoms of menopause, relaxing muscles, reducing nervous tension, reducing premenstrual syndrome symptoms, decreasing edema, reducing the volume/circumference of the legs, decreasing pain and tension in the legs, maintaining bone mass, preventing osteoporosis, fighting fatigue associated with anemia, preventing anemiaACTIVEDec 28, 2017

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 24, 2022NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
May 24, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 2, 2022SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Apr 1, 2022CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Mar 28, 2022SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Mar 25, 2022IUAFUSE AMENDMENT FILED—
Mar 25, 2022EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Oct 2, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 1, 2021EX5GSOU EXTENSION 5 GRANTED—
Sep 22, 2021EXT5SOU EXTENSION 5 FILED—
Sep 22, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 11, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 9, 2021EX4GSOU EXTENSION 4 GRANTED—
Mar 9, 2021EXT4SOU EXTENSION 4 FILED—
Mar 9, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 29, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 25, 2020EX3GSOU EXTENSION 3 GRANTED—
Sep 25, 2020EXT3SOU EXTENSION 3 FILED—
Sep 25, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 12, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 10, 2020EX2GSOU EXTENSION 2 GRANTED—
Mar 10, 2020EXT2SOU EXTENSION 2 FILED—
Mar 10, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 14, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 14, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 13, 2019NOACCORRECTED NOA E-MAILED—
Nov 12, 2019DPCCDIVISIONAL PROCESSING COMPLETE—
Nov 12, 2019AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Oct 29, 2019DRRRDIVISIONAL REQUEST RECEIVED—
Oct 29, 2019ERTDTEAS REQUEST TO DIVIDE RECEIVED—
Sep 27, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 25, 2019EX1GSOU EXTENSION 1 GRANTED—
Sep 25, 2019EXT1SOU EXTENSION 1 FILED—
Sep 25, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 26, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 29, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 29, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 9, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 19, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 19, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 19, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 19, 2018ALIEASSIGNED TO LIE—
Dec 14, 2018ALIEASSIGNED TO LIE—
Dec 10, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 30, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 30, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 30, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 23, 2018DOCKASSIGNED TO EXAMINER—
Jul 23, 2018TAEATEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED—
Jul 23, 2018PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Jul 9, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—

Frequently asked questions

Related guidance